Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Judge grills 9 Trump lawyers on fraud claims

<< Previous

Bullboard Posts

Next >>

Comment by Kingpin68on Jul 13, 2021 1:38pm

214 Views

Post# 33536431

RE:RE:Judge grills 9 Trump lawyers on fraud claims

Politics on the TLT board, why?? In the next Quarterly at the end of this month, we'll learn the results of the pending 3 patients of 6 who received the correct dosing. 2 of the 3 already had a CR/complete response. If even one more of the pending 3 is CR, that's 50% for that subgroup alone, which is better than any other treatment if it holds. It could potentially be 4 or 5 out of 6. If that happens, look out, this thing gets the green light to load up IMO.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide